<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>The Use of Machine Learning Methods to the Automated Atherosclerosis Diagnostic and Treatment System Development</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Maria Demchenko</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Irina Kashirina</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Voronezh State University</institution>
          ,
          <addr-line>Voronezh 394018</addr-line>
          ,
          <country country="RU">Russia</country>
        </aff>
      </contrib-group>
      <fpage>240</fpage>
      <lpage>252</lpage>
      <abstract>
        <p>The main objective of this study is a comprehensive analysis of an atherosclerosis disease with the use of various machine learning algorithms. One of the primary goals of this study was to develop effective diagnostic models for this disease. The real deidentified medical datasets were used for the models training, in particular, a sample of the MIMIC-III database. The use of the specialized Microsoft Azure Machine Learning platform within this study allowed us to develop highly efficient, scalable, and reusable classification models for atherosclerosis diagnostics. A significant part of the study was also devoted to working with the dataset of the Voronezh Regional Cardiology Dispensary. This dataset, containing real non-personalized data from more than 500 patients, allowed us to obtain the models for identifying the most significant predictors and markers of the atherosclerosis disease. With the purpose of the improvement of the existing models' quality, an automated system is currently being developed the cardiologist's workplace. This application, developed using the .NET Core and the Angular framework, allows to keep track of patients' and doctors' appointments, as well as save the patients' medical data as diagnoses and prescriptions. The further extension of the medical data obtained will help us to create a comprehensive system that would allow us to identify the most optimal patient treatment strategies using the Markov Decision Process approach.</p>
      </abstract>
      <kwd-group>
        <kwd>machine learning</kwd>
        <kwd>classification</kwd>
        <kwd>Microsoft Azure Machine Learning</kwd>
        <kwd>LightGBM</kwd>
        <kwd>XGBoostClassifier</kwd>
        <kwd>RandomForest</kwd>
        <kwd>ExtremeRandomTrees</kwd>
        <kwd>atherosclerosis</kwd>
        <kwd>ROC</kwd>
        <kwd>AUC</kwd>
        <kwd>reinforcement learning</kwd>
        <kwd>Markov Decision Process</kwd>
        <kwd>automated doctor's workplace</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>
        A key aspect of successful treatment is the timely diagnosis of a disease. Often,
pathology can begin to develop asymptomatically, sometimes at an early age, eventually
worsening the patient's quality of life and health. In particular, the symptoms of the
atherosclerosis disease can be found among 17% of people between the ages of 13-19
years, and by the age of 40 years, at least one atherosclerotic lesion is present in more
than 70% of patients [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]. The high prevalence of this disease, as well as the
accompanying high risk of vascular damage and ischemic lesions of organs, requires the
thorough research and the development of the most effective diagnostic methods and
treatment policies.
      </p>
      <p>
        Lots of up-to-date machine learning methods have shown high efficiency in solving
various medical problems. The most highly productive machine learning algorithms are
often used to solve medical diagnostic problems. One of the most popular approaches
is deep learning, which is actively used, in particular, in the task of diagnostics of the
life-threatening diseases, which is illustrated in [
        <xref ref-type="bibr" rid="ref2 ref3">2,3</xref>
        ]. At the same time, a significant
part of the studies nowadays is devoted to the application of the effective machine
learning methods to the research of cardiovascular diseases. For example, in [
        <xref ref-type="bibr" rid="ref4 ref5">4,5</xref>
        ], an
approach to the diagnosis of peripheral arterial diseases using supervised machine
learning methods was demonstrated. Therefore, the most efficient machine learning
methods have been chosen as the toolkit for the development of an automated
diagnostic system and the selection of optimal atherosclerosis treatment policies.
      </p>
      <p>
        The task of developing a system for atherosclerosis diagnostics and treatment
prescriptions was set by the specialists of the Voronezh Regional Cardiological Dispensary
(VOCD). This research includes the following main stages.
1. The development of the non-invasive atherosclerosis diagnostic models. The
solution to this problem involves 2 main steps.
a. Development of diagnostic models using the dataset provided by the VOCD. As
a training sample, this study used data collected within a research conducted
among 522 adult patients from the Bogucharsky district of the Voronezh region
using multichannel volume sphygmography (MVS) – an efficient non-invasive
method for atherosclerosis diagnostics [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ] aimed at identifying the significant
asymmetry of systolic blood pressure (SBP) on the arms or legs (ArmsIndex and
LegsIndex, respectively), as well as the ankle-brachial index (ABI). The
threshold value of the ABI indicator is an approved and generally accepted diagnostic
marker, while the pressure asymmetry coefficients ArmsIndex and LegsIndex
are still currently the subject of study. In particular, studies [
        <xref ref-type="bibr" rid="ref7 ref8 ref9">7-9</xref>
        ] have been
devoted to the identifying of the SBP asymmetry parameters, which also can be
considered as diagnostic features of atherosclerosis. In this study, neural network
models (binary classifier of MLP architecture, self-organizing Kohonen maps)
[
        <xref ref-type="bibr" rid="ref10">10</xref>
        ], as well as ensemble models (RandomForest, ExtremeRandomTrees,
XGBoostClassifier) [
        <xref ref-type="bibr" rid="ref11">11</xref>
        ] were used to find the most informative values of the
SBP asymmetry coefficients and use them as the basis for the calculation of the
atherosclerosis markers values.
b. Development of the diagnostic models using a sample of the international
database MIMIC-III. Unfortunately, the size of the regional sample is not sufficient
to obtain an expandable and generalizable solution; moreover, this sample
contains only the data on atherosclerosis disease. Due to this reason, in addition to
the regional sample, the current study included MIMIC-III datasets containing
medical records on ICU admissions at a Boston Medical Center from 2001 to
2012. Also at this stage of the study, the Azure Machine Learning platform was
used as a tool for building diagnostic models, which allowed to develop scalable
solutions with the possibility of deployment and continuous training. [
        <xref ref-type="bibr" rid="ref12">12</xref>
        ]
2. The development of the optimal patients’ treatment strategies using efficient
reinforcement learning models. The most recent machine learning approaches, for
example, reinforcement learning, allow not only to diagnose, but also to develop
optimal policies for treating patients with a specific diagnosis and health condition. In
particular, in [
        <xref ref-type="bibr" rid="ref13">13</xref>
        ] the solution to the problem of treating sepsis using reinforcement
learning is provided. It is also well-known that reinforcement learning is nowadays
used in some mobile health systems [
        <xref ref-type="bibr" rid="ref14">14</xref>
        ], that help to continuously monitor the
patient's treatment progress and adjust treatment strategies online.
3. The development of an automated system for collecting medical information,
including patients’ diagnoses and doctors’ appointments, as well as performing
administrative functions (registering patients, scheduling consultations with a doctor, etc.).
According to this purpose, we have developed an application for patients and
doctors, which allows to continuously track the condition, diagnoses and treatment
prescriptions of patients and their appointments with the doctors, and collect new data
to train and improve models. A significant advantage provided by the development
of such a system is the collection of regional data, which contributes to the
development of models that consider the local characteristics (climatic, social, etc.) in the
most efficient way.
2
      </p>
    </sec>
    <sec id="sec-2">
      <title>Atherosclerosis Diagnostic Models and Methods</title>
      <p>
        The solution of the problem of atherosclerosis diagnostics implied the building of the
classification models of high-quality, trained on medical datasets containing
information about patients suffering from this disease. Within this task, we performed a
comprehensive analysis of the patients dataset provided by the Voronezh Regional
Cardiology Dispensary [
        <xref ref-type="bibr" rid="ref10 ref11">10,11</xref>
        ]. A model developed using this sample reflects the patterns
in medical observations that are specific for particular cohorts of patients. At the same
time, during this investigation, we proved the effectiveness of the main atherosclerosis
markers – ArmsIndex, LegsIndex and ABI, which provide quite simple, but efficient
diagnostic methods.
      </p>
      <p>However, the disadvantage of such a sample is its rather small size, therefore, in
order to solve this problem at the next stage of the study, it was required to use a dataset
containing a larger number of patients’ observations. Within this work the MIMIC-III
datasets containing the arrays of patents’ data who admitted to critical care units at a
large tertiary care hospital were studied. Due to having a large MIMIC-III dataset
sample we were able to build a model trained on many different cases and taking into
account a wide range of factors and dependencies that affect the diagnostic results.
2.1</p>
      <sec id="sec-2-1">
        <title>The Task of the Atherosclerosis Markers and Predictors Analysis.</title>
      </sec>
      <sec id="sec-2-2">
        <title>The Dataset of the Voronezh Regional Cardiology Dispensary</title>
        <p>Arterial hypertension (AH), stenocardia, infarction, acute disorder of
cerebral circulation (ADCC), coronary artery bypass
grafting/percutaneous intervention (CABG/PCI), diabetes, chronic heart failure
(CHF), atrial flutter and atrial fibrillation (AF), obesity</p>
        <p>Within this research we were able to identify and prove the diagnostic efficiency of
the main atherosclerosis markers (represented by equations (1)-(3), where ABIr/ABIl
is right/left ankle-brachial index, SBPa/SBPl is arms/legs systolic blood pressure).</p>
        <p>1, if SBPa  14
ArmsIndex   . (1)
 0, otherwise</p>
        <p>1, if ABIr  0.9
ABI   . (3)
</p>
        <p>
          As a result of this research we were able to develop the efficient, though quite simple
method of atherosclerosis diagnostics, which doesn’t assume the execution of any
complex laboratory or clinical tests or hospitalizations. We also managed to identify the set
of atherosclerosis predictors, highly associated with this diagnosis (heart rate, arterial
hypertension, diabetes mellitus, age, height, weight, chronic heart failure). The details
and results of this research can be found in [
          <xref ref-type="bibr" rid="ref10 ref11">10,11</xref>
          ]
        </p>
        <p>The models trained on the dataset under consideration reflect local and regional
dependences with high accuracy. However, often (for example when the purpose is
delivering and integrating the developed solution in the live environment) it is also important
to take into account the most general dependencies and data samples of a larger size,
which are highly representative and include many observations.</p>
        <p>(2)
2.2</p>
      </sec>
      <sec id="sec-2-3">
        <title>Automated Experiments Based on Microsoft Azure Machine Learning</title>
      </sec>
      <sec id="sec-2-4">
        <title>Platform Using the MIMIC-III Data</title>
        <p>
          MIMIC-III sample of a patients having atherosclerosis. MIMIC-III database [
          <xref ref-type="bibr" rid="ref16">16</xref>
          ]
(«Medical Information Mart for Intensive Care») is a large, single-center database
comprising information relating to patients admitted to critical care units at a large tertiary
care hospital in Boston (Massachusetts). Data includes vital signs, medications,
laboratory measurements, observations and notes charted by care providers, fluid balance,
procedure codes, diagnostic codes, imaging reports, hospital length of stay, survival
data, and more.
        </p>
        <p>Within this study, aimed at atherosclerosis disease investigation, we prepared a
dataset containing a sample of laboratory (glucose, cholesterol, creatinine) and clinical
(diabetes, history of myocardial infarction) features. A fragment of the original sample
is shown in Table 2.</p>
        <p>The graph displaying the pairwise laboratory features distribution considering the
atherosclerosis diagnosis approved or not is shown in Fig. 1, along with 7 different
kinds of atherosclerosis specified.</p>
      </sec>
      <sec id="sec-2-5">
        <title>Classification models building using Azure ML. Based on this sample, the task of</title>
        <p>the patients’ classification based on the laboratory and clinical features was solved. In
this case, the “Atherosclerosis” field of the dataset, representing whether the patient has
atherosclerosis diagnosis or not, was chosen as a target (output) variable.</p>
        <p>Usually the solution of the machine learning problems involves time-consuming
steps of the models setting up and selection, as well as the calibration of
hyperparameters, which sometimes is a complex and long-term process. However, the development
of the current technologies allows us to automate these steps, which can significantly
reduce costs and optimize the obtaining of models that have the highest quality metrics.</p>
        <p>In particular, in this study, we examined the capabilities of the Microsoft Azure
Machine Learning platform, which allowed us to conduct many experiments (iterations of
building and training models) on different versions of data sets.</p>
        <p>
          The multiple experiments (classification models training, testing and validation
iterations) were run using the MIMIC-III dataset sample and such classification methods
as RandomForest, ExtremeRandomTrees, XGBoostClassifier (the detailed description
of these algorithms are provided in [
          <xref ref-type="bibr" rid="ref11">11</xref>
          ]), as well as gradient boosting framework
LightGBM.
        </p>
        <p>The advantages of this framework are its high performance and training speed, low
memory costs, and also the high calculation accuracy.</p>
        <p>
          The high efficiency of this framework is a result of the optimized tree growth
algorithm. In opposite to the majority of the decision tree learning algorithms, that grow
trees by level (depth-wise), LightGBM grows trees leaf-wise (best-first), which is
displayed in Fig. 2. [
          <xref ref-type="bibr" rid="ref17">17</xref>
          ]
        </p>
        <p>Metrics and models’ performance. The initial sample is a large sample containing
7021 records of patient diagnoses. Moreover, this sample is balanced, because the
proportion of patients with diagnosed atherosclerosis in the entire sample was 53% (3722
cases, 3299 healthy patients).</p>
        <p>The Azure Machine Learning platform provides a number of built-in quality metrics
for classification models, including Accuracy, Weighted accuracy, Average precision
score macro / micro / weighted, AUC macro / micro / weighted, etc. An important step
of the classification task is to determine the metrics for the current analysis with the
highest priority.</p>
        <p>Often the optimal approach for assessing the accuracy of medical diagnostic models
is ROC-curves, and the area under the ROC-curve AUC is the primary aggregated
quality metric. The Weighted AUC criterion, in its turn, is an extension to AUC that takes
into account the weights of each class in the dataset target variable. Consequently, the
performance of the final classifiers was evaluated, primarily, using the weighted AUC
criterion.
3</p>
      </sec>
    </sec>
    <sec id="sec-3">
      <title>The Results of Atherosclerosis Diagnostics Task Solution</title>
      <p>
        As a result of the research using the data of clinical patients’ examination in the
Bogucharsky district, diagnostic models, described in Table 3, were built. This sample was
unbalanced (the rate of patients with atherosclerosis was only 14%), therefore, in
particular, ensemble models with built-in class balancing algorithms were considered. The
model of the highest quality contained the ABI marker as a diagnostic feature and
reflected its dependency on the patient's hemodynamic parameters. [
        <xref ref-type="bibr" rid="ref11">11</xref>
        ]
      </p>
      <p>The building of the atherosclerosis classification models based on the MIMIC-III
dataset using the Microsoft Azure Machine Learning cloud-based platform allowed to
carry out a series of iterations for building the classification models using such
frameworks and methods as LightGBM, XGBoostClassifier, RandomForest, and
ExtremeRandomTrees. The models were compared primarily based on the weighted AUC
metric. The list of 10 best models is shown in Table 4.</p>
      <p>The model with the maximum weighted AUC (0.85746) was built using the
LightGBM classifier and the Max-AbsScaler standardization algorithm. Moreover, in
addition to AUC, other metrics were calculated. Quality metrics of the best classifier
are given in Table 5.</p>
      <p>Also, the Azure Machine Learning platform provides tools for visualization and
interpretation of the generated models. For example, Fig. 3 illustrates the graph of ROC
curves, and Fig. 4 shows an automatically generated confusion matrix.</p>
    </sec>
    <sec id="sec-4">
      <title>The Task of Obtaining Optimal Treatment Strategies</title>
      <p>The importance of timely atherosclerosis diagnostics can be approved by many medical
experts. However, an equally important task is the development and prescription of a
most efficient treatment strategies, which can be solved successfully using the
up-todate reinforcement learning methods.</p>
      <p>
        Reinforcement learning is one of the most actively developing areas in artificial
intelligence. It is a computational approach to learning whereby an agent tries to
maximize the total amount of reward it receives while interacting with a complex, uncertain
environment. [
        <xref ref-type="bibr" rid="ref18">18</xref>
        ]
4.1
      </p>
      <sec id="sec-4-1">
        <title>Reinforcement Learning Model in the Clinical Trials Problems</title>
        <p>The task of conducting clinical trials and prescribing optimal strategies for treating
patients is one of the many areas of reinforcement learning application. In this case, the
model under consideration is a Markov Decision Process with a defined set of states,
actions and rewards.</p>
        <p>1. We define sets of patient’s parameters at each stage of treatment (for example,
systolic blood pressure, pulse, blood cholesterol, etc.) as a set of states.
2. This problem can be formulated as a series of treatment episodes, where each
episode represents one of the possible treatment outcomes. An episode is considered
as completed if the patient was successfully discharged from the hospital,
transferred to another department, or in case of the patient's death - we define these
outcomes as terminal states.
3. We define actions as the chosen treatment strategies at each treatment step
(medications, procedures etc.).
4. We define rewards as zero if the treatment is being continued, positive in case of
the patient’s discharge or getting better, or negative in the case of patient’s death or
getting worse.
5. Thus, the agent’s goal will be to identify and further follow the treatment strategy
leading to maximum total reward.</p>
        <p>A schematic example of this process is illustrated in Fig. 5.</p>
        <p>Among the key features of the model, the following should be specified:
1. An array of data is a collection of large amounts of medical information.
2. It is necessary to take into account the change in the patient's state, and,
consequently, the agent's reward, not only at the end of the episode, but also at each step
of the episode (continuous treatment process).
3. It is necessary not only to train the agent to act according to the optimal treatment
strategy, but also to identify the most efficient treatment policies leading to the
maximum reward for each of the possible conditions.</p>
        <p>The solution of the reinforcement learning problems is technically the solution of
optimization problems with respect to the objective function Q(s,a), which
approximates the total rewards of the agent who chooses action a, being in state s (where a is
one of the possible actions of the treatment strategy). Therefore, in order to approximate
this function on a large amount of data in the most accurate way, deep learning neural
networks will be used.</p>
        <p>In order to take into account properties 2 and 3 of this problem, the Q-Learning
algorithm is applied.</p>
        <p>The development of a reinforcement learning model is the current step of this study.
The most suitable dataset for such a solution is the MIMIC-III dataset containing a
history of medical treatments, procedures and prescribed drugs.</p>
      </sec>
    </sec>
    <sec id="sec-5">
      <title>The Development of the Automated Cardiologist’s Workplace</title>
      <p>The development and further performance improvement of machine learning models is
inseparably linked with the continuous updating of a data array with the most relevant
incoming information.</p>
      <p>Usually, this process can be set up using the automated systems and applications that
control the data flow and history and optimize many processes that the specialists
(doctors) should perform on a daily basis.</p>
      <p>The aim of this study is to develop an automated application to manage and support
the work of a specialist (cardiologist) in examining and treating patients with a
specialized pathology (diseases of the cardiovascular system).</p>
      <p>The application is considered as a tool which helps to reduce the time to perform the
doctor’s auxiliary operations, related to medical data input, storage, search and analysis.
The application, implementing the artificial intelligence features, should manage the
decision making process tasks, executed by doctors, and support the remote patients’
monitoring.
5.1</p>
      <sec id="sec-5-1">
        <title>Key Application Features</title>
        <p>A list of some of the specific features of the application in development:
1. Compliance with legal requirements and regulations on the protection of personal
and medical data (medical databases), as well as the storage of medical information.
2. Fast medical data entry using the contextual dictionaries.
3. Facilitated input (transfer) of digital, textual and graphic data from various
thirdparty medical protocols and conclusions into the application.
4. Automatic integration and merging of various types ("blocks") of medical
information for a particular patient at a specific point in time or at a specific time
interval.
5. An automatic patient scheduler with a list of tasks and their implementations.
6. The module for notifying patients (SMS, e-mail, Viber, WhatsApp) about assigned
tasks and scheduled appointments.
7. Interactive module for the remote monitoring via SMS or a separate mobile
application of the patient's condition according to the selected parameters and scenarios.
8. Evaluation of a short-term prognosis based on data obtained using the module for
remote monitoring of the patient's condition.
9. The presence of flexibly customizable queries for data search both by patient groups
and by individual patients, including the generation of various statistical reports.
10. Digital Signature Support.
11. Support for the medical decision making process in individual problems of
diagnosis and treatment assignment using artificial intelligence.
5.2</p>
      </sec>
      <sec id="sec-5-2">
        <title>The Main Components of the Application</title>
        <p>The developed automated system includes such components as:
─ Web application for doctors, which is used to enter and search for medical
information, appointments and consultations scheduling;
─ A mobile application for patients, used to track patient health condition and schedule
appointments with a doctor;
─ A database containing medical information, including patients’ data.
5.3</p>
      </sec>
      <sec id="sec-5-3">
        <title>Patient Information Module</title>
        <p>The application’s module responsible for the basic logic of registration and subsequent
maintenance of the patients’ information includes such features as:
─ The creation of a medical card with the minimum necessary information about the
patient;
─ Scheduling and tracking the patients’ appointments with the doctors for the purpose
of consultation, observation, diagnostic or other medical procedures;
─ The storage of a list of medical prescriptions and diagnoses for the patient.</p>
        <p>Thus, having the minimum necessary set of basic features, this application supports
the functions of collecting and storing the medical information (the diagnoses and
prescriptions of patients, scheduled appointments with doctors).</p>
        <p>The main goal of the application is to provide the support for the primary
atherosclerosis diagnostics, as well as intended to support the automatic selection of optimal
treatment policies.
6</p>
      </sec>
    </sec>
    <sec id="sec-6">
      <title>Conclusion</title>
      <p>
        As a result of the current research, a complete analysis of the atherosclerosis disease
was carried out. This research can be considered as a sequence of the following stages.
1. Identification of the most significant markers and predictors of atherosclerosis and
building the diagnostic models of atherosclerosis using the data set of the Voronezh
Regional Cardiological Dispensary. This stage was implemented within the research
[
        <xref ref-type="bibr" rid="ref10 ref11">10,11</xref>
        ].
2. The development of a generalized model for the atherosclerosis diagnostics using a
large dataset. At the current stage of the study, using a sample of MIMIC-III data, it
was possible to develop highly efficient, flexible and scalable diagnostic models ,
available for the further deployment.
3. Within the current study, a system for identifying the optimal atherosclerosis
treatment strategies based on the reinforcement learning methods was modelled.
Optimization and deployment of this model is planned as the next stage of the study.
4. In order to support and improve the functioning of the created models, an automated
cardiologist’s workplace is also being developed – which is a system that allows you to
collect and save the relevant medical information: prescriptions and diagnoses made by
doctors, patient visits and health condition. Further collection of the medical
information will continuously provide the most relevant data for training the system and for
achieving the most accurate diagnostic results and developing optimal treatment
policies for the disease.
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          1.
          <string-name>
            <surname>Tuzcu</surname>
            ,
            <given-names>E.M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kapadia</surname>
            ,
            <given-names>S.R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Tutar</surname>
            ,
            <given-names>E.</given-names>
          </string-name>
          et al.:
          <article-title>High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound</article-title>
          .
          <source>Circulation</source>
          <volume>103</volume>
          (
          <issue>22</issue>
          ),
          <fpage>2705</fpage>
          -
          <lpage>2710</lpage>
          (
          <year>2001</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          2.
          <string-name>
            <surname>Reddy</surname>
            ,
            <given-names>A.V.N.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Krishna</surname>
            ,
            <given-names>C.P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Mallick</surname>
            ,
            <given-names>P.K.</given-names>
          </string-name>
          et al.
          <article-title>Analyzing MRI scans to detect glioblastoma tumor using hybrid deep belief networks</article-title>
          .
          <source>J Big Data</source>
          <volume>7</volume>
          ,
          <issue>35</issue>
          (
          <year>2020</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          3.
          <string-name>
            <surname>Jaiswal</surname>
            ,
            <given-names>A.K.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Tiwari</surname>
            ,
            <given-names>P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kumar</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gupta</surname>
            ,
            <given-names>D.R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Khanna</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          , &amp;
          <string-name>
            <surname>Rodrigues</surname>
            ,
            <given-names>J.J.</given-names>
          </string-name>
          (
          <year>2019</year>
          ).
          <article-title>Identifying pneumonia in chest X-rays: A deep learning approach</article-title>
          .
          <source>Measurement</source>
          ,
          <volume>145</volume>
          ,
          <fpage>511</fpage>
          -
          <lpage>518</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          4.
          <string-name>
            <surname>Ross</surname>
            <given-names>EG</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Shah</surname>
            <given-names>NH</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Dalman</surname>
            <given-names>RL</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Nead</surname>
            <given-names>KT</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Cooke</surname>
            <given-names>JP</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Leeper</surname>
            <given-names>NJ</given-names>
          </string-name>
          .
          <article-title>The use of machine learning for the identification of peripheral artery disease and future mortality risk</article-title>
          .
          <source>J Vasc Surg</source>
          .
          <year>2016</year>
          ;
          <volume>64</volume>
          (
          <issue>5</issue>
          ):
          <fpage>1515</fpage>
          -
          <lpage>1522</lpage>
          .
          <year>e3</year>
          . doi:
          <volume>10</volume>
          .1016/j.jvs.
          <year>2016</year>
          .
          <volume>04</volume>
          .026.
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          5.
          <string-name>
            <surname>Duval</surname>
            <given-names>S</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Massaro</surname>
            <given-names>JM</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Jaff</surname>
            <given-names>MR</given-names>
          </string-name>
          , et al.
          <article-title>An evidence-based score to detect prevalent peripheral artery disease (PAD)</article-title>
          .
          <source>Vasc Med</source>
          .
          <year>2012</year>
          ;
          <volume>17</volume>
          (
          <issue>5</issue>
          ):
          <fpage>342</fpage>
          -
          <lpage>351</lpage>
          . doi:
          <volume>10</volume>
          .1177/1358863X12445102.
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          6.
          <string-name>
            <surname>Khokhlov</surname>
            ,
            <given-names>R.A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gaydashev</surname>
            ,
            <given-names>A.E.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Ostroushko</surname>
            <given-names>N.I.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gaydashev A.E.</surname>
          </string-name>
          <article-title>: Multi-channel volume sphygmography in cardioangiological screening of the adult population</article-title>
          .
          <source>Rational Pharmacotherapy in Cardiology</source>
          <volume>11</volume>
          (
          <issue>4</issue>
          ),
          <fpage>371</fpage>
          -
          <lpage>379</lpage>
          (
          <year>2015</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          7.
          <string-name>
            <surname>Weinberg</surname>
            <given-names>I.</given-names>
          </string-name>
          , et al.
          <article-title>The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study</article-title>
          .
          <source>The American Journal of Medicine</source>
          <year>2014</year>
          :
          <volume>127</volume>
          ;
          <fpage>209</fpage>
          -
          <lpage>15</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          8.
          <string-name>
            <surname>Clark</surname>
            <given-names>CE</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Taylor</surname>
            <given-names>RS</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Shore</surname>
            <given-names>AC</given-names>
          </string-name>
          , et al.
          <article-title>Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis</article-title>
          .
          <source>Lancet</source>
          <year>2012</year>
          :
          <volume>380</volume>
          (
          <issue>9838</issue>
          ):
          <fpage>218</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          9. Mitchell E.
          <article-title>Noninvasive diagnosis of arterial disease</article-title>
          .
          <string-name>
            <surname>Up-ToDate</surname>
            <given-names>URL</given-names>
          </string-name>
          : https://www.uptodate.com/contents/noninvasive
          <article-title>-diagnosis-of-arterial-disease.</article-title>
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          10.
          <string-name>
            <surname>Lvovich</surname>
            <given-names>Y.E.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kashirina</surname>
            <given-names>I.L.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Demchenko</surname>
            <given-names>M.V.</given-names>
          </string-name>
          <article-title>The Use of Machine Learning Methods to Study Markers of Atherosclerosis of the Great Arteries</article-title>
          .
          <source>Information technology 26(1)</source>
          ,
          <fpage>46</fpage>
          -
          <lpage>55</lpage>
          (
          <year>2020</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation>
          11.
          <string-name>
            <surname>Demchenko</surname>
            ,
            <given-names>M.V.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kashirina</surname>
            ,
            <given-names>I.L.</given-names>
          </string-name>
          :
          <article-title>The development of the atherosclerosis diagnostic models under conditions of unbalanced classes</article-title>
          .
          <source>J. Phys.: Conf. Ser. 1479</source>
          <volume>012026</volume>
          (
          <year>2020</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation>
          12.
          <string-name>
            <surname>Azure</surname>
          </string-name>
          Machine Learning documentation https://docs.microsoft.com/en-us/azure/machinelearning/,
          <source>last accessed</source>
          <year>2020</year>
          /5/31.
        </mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation>
          13.
          <string-name>
            <surname>Komorowski</surname>
            <given-names>M</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Celi</surname>
            <given-names>LA</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Badawi</surname>
            <given-names>O</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gordon</surname>
            <given-names>AC</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Faisal</surname>
            <given-names>AA</given-names>
          </string-name>
          .
          <article-title>The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care</article-title>
          .
          <source>Nat Med</source>
          .
          <year>2018</year>
          ;
          <volume>24</volume>
          (
          <issue>11</issue>
          ):
          <fpage>1716</fpage>
          -
          <lpage>1720</lpage>
          . doi:
          <volume>10</volume>
          .1038/s41591-018-0213-5.
        </mixed-citation>
      </ref>
      <ref id="ref14">
        <mixed-citation>
          14.
          <string-name>
            <surname>Istepanian</surname>
            <given-names>RSH</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Al-Anzi T.</surname>
          </string-name>
          m
          <article-title>-Health 2.0: New perspectives on mobile health, machine learning and big data analytics</article-title>
          .
          <source>Methods</source>
          .
          <year>2018</year>
          ;
          <volume>151</volume>
          :
          <fpage>34</fpage>
          -
          <lpage>40</lpage>
          . doi:
          <volume>10</volume>
          .1016/j.ymeth.
          <year>2018</year>
          .
          <volume>05</volume>
          .015.
        </mixed-citation>
      </ref>
      <ref id="ref15">
        <mixed-citation>
          15.
          <string-name>
            <surname>Khokhlov</surname>
            ,
            <given-names>R.A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gaydashev</surname>
            ,
            <given-names>A.E.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Akhmedzhanov</surname>
            <given-names>N.M.:</given-names>
          </string-name>
          <article-title>Predictors of atherosclerotic lesions of limb arteries according to cardioangiological screening of the adult population</article-title>
          .
          <source>Rational Pharmacotherapy in Cardiology</source>
          <volume>11</volume>
          (
          <issue>5</issue>
          ),
          <fpage>470</fpage>
          -
          <lpage>476</lpage>
          (
          <year>2015</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref16">
        <mixed-citation>
          16.
          <string-name>
            <surname>Johnson</surname>
            ,
            <given-names>A. E. W.</given-names>
          </string-name>
          et al.
          <article-title>MIMIC-III, a freely accessible critical care database</article-title>
          .
          <source>Sci. Data</source>
          <volume>3</volume>
          ,
          <issue>160035</issue>
          (
          <year>2016</year>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref17">
        <mixed-citation>
          17. LightGBM documentation, https://lightgbm.readthedocs.io/en/latest/,
          <source>last accessed</source>
          <year>2020</year>
          /5/31.
        </mixed-citation>
      </ref>
      <ref id="ref18">
        <mixed-citation>
          18.
          <string-name>
            <surname>Sutton</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Barto</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          :
          <article-title>Reinforcement learning</article-title>
          .
          <source>2nd edn</source>
          . The MIT Press, Cambridge (
          <year>2018</year>
          ).
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>